Countries citing papers authored by Peter Kirkpatrick
Since
Specialization
Citations
This map shows the geographic impact of Peter Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kirkpatrick more than expected).
Fields of papers citing papers by Peter Kirkpatrick
This network shows the impact of papers produced by Peter Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kirkpatrick. The network helps show where Peter Kirkpatrick may publish in the future.
Co-authorship network of co-authors of Peter Kirkpatrick
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kirkpatrick.
A scholar is included among the top collaborators of Peter Kirkpatrick based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Peter Kirkpatrick. Peter Kirkpatrick is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Grünfeld, Carl, Argyris Dritselis, & Peter Kirkpatrick. (2011). High Precision and Stable Four Axis CNC Machining Center. Nature Reviews Drug Discovery. 10(2). 95–96.5 indexed citations
5.
Grünfeld, Carl, Argyris Dritselis, & Peter Kirkpatrick. (2011). Plastic Injection Moulding. Nature Reviews Drug Discovery. 10(2). 95–96.
6.
Huber, Kurt, Bashar Hamad, & Peter Kirkpatrick. (2011). Ticagrelor. Nature Reviews Drug Discovery. 10(4). 255–256.24 indexed citations
7.
Meltzer, Herbert Y., Argyris Dritselis, Uma Yasothan, & Peter Kirkpatrick. (2009). Asenapine. Nature Reviews Drug Discovery. 8(11). 843–844.15 indexed citations
8.
Bork, Konrad, et al.. (2008). Icatibant. Nature Reviews Drug Discovery. 7(10). 801–802.30 indexed citations
9.
Moy, Beverly, Peter Kirkpatrick, Santwana Kar, & Paul E. Goss. (2007). Lapatinib. Nature Reviews Drug Discovery. 6(6). 431–432.127 indexed citations
10.
Rini, Brian I., Santwana Kar, & Peter Kirkpatrick. (2007). Temsirolimus. Nature Reviews Drug Discovery. 6(8). 599–600.28 indexed citations
11.
Saltz, Leonard B., et al.. (2006). Panitumumab. Nature Reviews Drug Discovery. 5(12). 987–988.51 indexed citations
Dowell, Jonathan E., John D. Minna, & Peter Kirkpatrick. (2005). Erlotinib hydrochloride. Nature Reviews Drug Discovery. 4(5). S14–S15.24 indexed citations
14.
Buysse, Daniel J., et al.. (2005). Ramelteon. Nature Reviews Drug Discovery. 4(11). 881–882.24 indexed citations
15.
Kirkpatrick, Peter, et al.. (2004). Duloxetine hydrochloride. Nature Reviews Drug Discovery. 3(11). 907–908.18 indexed citations
16.
Kirkpatrick, Peter, et al.. (2003). Daptomycin. Fresh from the Pipeline. Nature Reviews Drug Discovery.14 indexed citations
17.
Kirkpatrick, Peter, et al.. (2003). Atazanavir Sulfate. Fresh from the Pipeline. Nature Reviews Drug Discovery.4 indexed citations
18.
Earl, John & Peter Kirkpatrick. (2003). Ezetimibe. Nature Reviews Drug Discovery. 2(2). 97–98.34 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.